The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time (Q28285897)

1

0 references

Vaggelis Harokopos

2

0 references

Christina Mylona-Karagianni

3

0 references

Emmanouil Tsouvalas

4

0 references

Vassilis Aidinis

5

0 references

Elli F Kamper

Macrophage inflammatory protein-1

6

0 references

language of work or name

English

0 references

publication date

September 2010

0 references

published in

Annals of Medicine

0 references

volume

42

0 references

issue

6

0 references

page(s)

426-38

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109/07853890.2010.495951

The CD40/CD154 receptor/ligand dyad

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/07853890.2010.495951

21 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Redefining the clinical remission period in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Regulation of autoimmune inflammation by pro-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Role of chemokines in endocrine autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Role of cytokines in the pathogenesis of autoimmune diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Cytokines and type 1 diabetes complications: casual or causal association?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

CD40 and its ligand in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Instability of hierarchical cluster analysis due to input order of the data: the PermuCLUSTER solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The Comparison of Dendrograms by Objective Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The role of inflammation in insulitis and beta-cell loss in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Interleukin 2: from immunostimulation to immunoregulation and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Biomarkers in cardiovascular diabetology: interleukins and matrixins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

CD40/CD40L signaling and its implication in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Immune intervention at diagnosis--should we treat children to preserve beta-cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Type 1 diabetes as a relapsing-remitting disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

The T(reg)/Th17 cell balance: a new paradigm for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-α-converting Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.495951

10.3109/07853890.2010.495951

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20568978

1 reference

Consolidated OpenCitations Corpus – April 2017